[1] |
Moran B, Silva R, Perry AS, et al. Epigenetics of malignant melanoma[J]. Semin Cancer Biol, 2018,51:80⁃88. doi: 10.1016/j.semcancer.2017.10.006.
|
[2] |
Chatterjee A, Stockwell PA, Ahn A, et al. Genome⁃wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis[J]. Oncotarget, 2017,8(4):6085⁃6101. doi: 10.18632/oncotarget. 14042.
|
[3] |
Wouters J, Vizoso M, Martinez⁃Cardus A, et al. Comprehensive DNA methylation study identifies novel progression⁃related and prognostic markers for cutaneous melanoma[J]. BMC Med, 2017,15(1):101. doi: 10.1186/s12916⁃017⁃0851⁃3.
|
[4] |
de Unamuno Bustos B, Murria Estal R, Pérez Simó G, et al. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma[J]. Br J Dermatol, 2018,179(2):394⁃404. doi: 10. 1111/bjd.16254.
|
[5] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)黑素瘤诊疗指南2017.V1[M]. 北京: 人民卫生出版社, 2017:1⁃111.
|
[6] |
何纯刚, 黄沁园, 钟世彪, 等. 结直肠腺瘤基因低甲基化谱分析及其标记物的筛选研究[J]. 结直肠肛门外科, 2018,24(1):1⁃5. doi: 10.19668/j.cnki.issn1674⁃0491.2018.01.001.
|
[7] |
Rosko AJ, Vankoevering KK, McLean SA, et al. Contemporary management of early⁃stage melanoma: a systematic review[J]. JAMA Facial Plast Surg, 2017,19(3):232⁃238. doi: 10.1001/ jamafacial.2016.1846.
|
[8] |
吴海竞, 付思祺, 李倩文, 等. 黑色素瘤的生物标志物:从基因组学到表观遗传学[J]. 协和医学杂志, 2018,9(1):60⁃68. doi: 10.3969/j.issn.1674⁃9081.2018.01.012.
|
[9] |
郭芳, 康晓静, 唐小辉, 等. 新疆80例恶性黑素瘤BRAF基因突变分析[J]. 中华皮肤科杂志, 2013,46(1):33⁃36. doi: 10. 3760/cma.j.issn.0412⁃4030.2013.01.013.
|
[10] |
Chen YA, Lemire M, Choufani S, et al. Discovery of cross⁃reactive probes and polymorphic CpGs in the illumina infinium human methylation 450 microarray[J]. Epigenetics, 2013,8(2):203⁃209. doi: 10.4161/epi.23470.
|
[11] |
Conway K, Edmiston SN, Khondker ZS, et al. DNA⁃methylation profiling distinguishes malignant melanomas from benign nevi[J]. Pigment Cell Melanoma Res, 2011,24(2):352⁃360. doi: 10.1111/j.1755⁃148X.2011.00828.x.
|
[12] |
Hallberg AR, Vorrink SU, Hudachek DR, et al. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma[J]. Epigenetics, 2014,9(12):1641⁃1647. doi: 10.4161/15592294. 2014.988062.
|
[13] |
Mosavi LK, Cammett TJ, Desrosiers DC, et al. The ankyrin repeat as molecular architecture for protein recognition[J]. Protein Sci, 2004,13(6):1435⁃1448. doi: 10.1110/ps.03554604.
|
[14] |
Hughey CC, Trefts E, Bracy DP, et al. Glycine N⁃methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates[J]. J Biol Chem, 2018,293(30):11944⁃11954. doi: 10.1074/jbc.RA118.002568.
|
[15] |
Greenhalgh CJ, Rico⁃Bautista E, Lorentzon M, et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo[J]. J Clin Invest, 2005,115(2):397⁃406. doi: 10.1172/JCI 22710.
|
[16] |
Van Den Eynde BJ, Gaugler B, Probst⁃Kepper M, et al. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription[J]. J Exp Med, 1999,190(12):1793⁃1800. doi: 10.1084/jem.190.12.1793.
|
[17] |
G·B·特伦布利, A·N·莫莱提斯, M·菲利翁, 等. 用于通过使用肾相关抗原1(KAAG1)的抑制剂来治疗三阴性乳癌和基底样乳癌的方法[P]. 中国专利: CN104955477B.2020⁃03⁃03 .
|
[18] |
Yamaki A, Akiyama R, Murakami C, et al. Diacylglycerol kinase α⁃selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines[J]. J Cell Biochem, 2019,120(6):10043⁃10056. doi: 10.1002/jcb.28288.
|
[19] |
Serrano A, Tanzarella S, Lionello I, et al. Rexpression of HLA class I antigens and restoration of antigen⁃specific CTL response in melanoma cells following 5⁃aza⁃2′⁃deoxycytidine treatment[J]. Int J Cancer, 2001,94(2):243⁃251. doi: 10.1002/ijc.1452.
|
[20] |
Seberg HE, Van Otterloo E, Loftus SK, et al. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF[J]. PLoS Genet, 2017,13(3):e1006636. doi: 10.1371/journal.pgen. 1006636.
|
[21] |
Wang T, Abou⁃Ouf H, Hegazy SA, et al. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients[J]. J Mol Med (Berl), 2016,94(12):1411⁃1422. doi: 10.1007/s00109⁃016⁃1458⁃4.
|
[22] |
Babina IS, McSherry EA, Donatello S, et al. A novel mechanism of regulating breast cancer cell migration via palmitoylation⁃dependent alterations in the lipid raft affiliation of CD44[J]. Breast Cancer Res, 2014,16(1):R19. doi: 10.1186/bcr3614.
|
[23] |
Lissa D, Ishigame T, Noro R, et al. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients[J]. Lung Cancer, 2018,122:151⁃159. doi: 10.1016/j.lungcan.2018.05.021.
|
[24] |
Park SM, Choi EY, Bae M, et al. A long⁃range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients[J]. Clin Epigenetics, 2017,9:73. doi: 10.1186/s13148⁃017⁃0373⁃z.
|
[25] |
Zhou C, Li J, Li Q, et al. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma[J]. J Clin Lab Anal, 2019,33(5):e22873. doi: 10. 1002/jcla.22873.
|
[26] |
Gao L, van den Hurk K, Moerkerk P, et al. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy[J]. J Invest Dermatol, 2014,134(12):2957⁃2966. doi: 10.1038/jid.2014.270.
|
[27] |
Marini A, Mirmohammadsadegh A, Nambiar S, et al. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma[J]. J Invest Dermatol, 2006,126(2):422⁃431. doi: 10.1038/sj.jid.5700073.
|
[28] |
Vojta A, Samaržija I, Bočkor L, et al. Glyco⁃genes change expression in cancer through aberrant methylation[J]. Biochim Biophys Acta, 2016,1860(8):1776⁃1785. doi: 10.1016/j.bbagen. 2016.01.002.
|
[29] |
Gao L, Smit MA, van den Oord JJ, et al. Genome⁃wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma[J]. Pigment Cell Melanoma Res, 2013,26(4):542⁃554. doi: 10.1111/pcmr.12096.
|